Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L A Kalish

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Journal of the National Cancer Institute|February 26, 1999
Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative womenJ M Palefsky, H Minkoff, L A Kalish, et al.
Cancer|May 15, 1993
Cisplatin, 5-fluorouracil, and etoposide for advanced non-small cell lung cancerT J Lynch, F Kass, L A Kalish, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 24, 2001
Qualitative and quantitative PCR measures of cytomegalovirus in patients with advanced HIV infection who require transfusionsM F Para, L A Kalish, A C Collier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Concurrent radiation therapy and chemotherapy for locally unresectable squamous cell head and neck cancer: an Eastern Cooperative Oncology Group pilot studyD J Adelstein, L A Kalish, G L Adams, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 1994
Phase I pharmacokinetic study of the hypoxic cell sensitizer etanidazole with carboplatin and cyclophosphamide in the treatment of advanced ovarian cancerL N Shulman, L Buswell, H Goodman, et al.
Epidemiology (Cambridge, Mass.)|March 21, 1998
The Women's Interagency HIV Study. WIHS Collaborative Study GroupS E Barkan, S L Melnick, S Preston-Martin, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 22, 1998
Seroprevalence of HTLV-I and HTLV-II among a cohort of HIV-infected women and women at risk for HIV infection. Women's Interagency HIV StudyE E Telzak, R Hershow, L A Kalish, et al.
AIDS (London, England)|October 6, 1999
The relative value of CD4 cell count and quantitative HIV-1 RNA in predicting survival in HIV-1-infected women: results of the women's interagency HIV studyK Anastos, L A Kalish, N Hessol, et al.
The New England Journal of Medicine|June 20, 1996
Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. The Women and Infants Transmission StudyS H Landesman, L A Kalish, D N Burns, et al.
The Journal of Infectious Diseases|October 9, 1999
Evaluation of human immunodeficiency virus (HIV) type 1 load, CD4 T cell level, and clinical class as time-fixed and time-varying markers of disease progression in HIV-1-infected childrenL A Kalish, K McIntosh, J S Read, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Journal of the National Cancer Institute|February 26, 1999
Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative womenJ M Palefsky, H Minkoff, L A Kalish, et al.
Cancer|May 15, 1993
Cisplatin, 5-fluorouracil, and etoposide for advanced non-small cell lung cancerT J Lynch, F Kass, L A Kalish, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 24, 2001
Qualitative and quantitative PCR measures of cytomegalovirus in patients with advanced HIV infection who require transfusionsM F Para, L A Kalish, A C Collier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Concurrent radiation therapy and chemotherapy for locally unresectable squamous cell head and neck cancer: an Eastern Cooperative Oncology Group pilot studyD J Adelstein, L A Kalish, G L Adams, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 1994
Phase I pharmacokinetic study of the hypoxic cell sensitizer etanidazole with carboplatin and cyclophosphamide in the treatment of advanced ovarian cancerL N Shulman, L Buswell, H Goodman, et al.
Epidemiology (Cambridge, Mass.)|March 21, 1998
The Women's Interagency HIV Study. WIHS Collaborative Study GroupS E Barkan, S L Melnick, S Preston-Martin, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 22, 1998
Seroprevalence of HTLV-I and HTLV-II among a cohort of HIV-infected women and women at risk for HIV infection. Women's Interagency HIV StudyE E Telzak, R Hershow, L A Kalish, et al.
AIDS (London, England)|October 6, 1999
The relative value of CD4 cell count and quantitative HIV-1 RNA in predicting survival in HIV-1-infected women: results of the women's interagency HIV studyK Anastos, L A Kalish, N Hessol, et al.
The New England Journal of Medicine|June 20, 1996
Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. The Women and Infants Transmission StudyS H Landesman, L A Kalish, D N Burns, et al.
The Journal of Infectious Diseases|October 9, 1999
Evaluation of human immunodeficiency virus (HIV) type 1 load, CD4 T cell level, and clinical class as time-fixed and time-varying markers of disease progression in HIV-1-infected childrenL A Kalish, K McIntosh, J S Read, et al.
Pageof 8